Head & Neck PD-L1
| 22C3 PharmDx | 28-8 PharmDx | SP142 Assay | SP263 Assay | |
|---|---|---|---|---|
| Atezolizumab | - | - | - | - |
| Durvalumab | - | - | - | - |
| Nivolumab | - | - | - | - |
| Pembrolizumab | 1L (CPS ≥1) companion, with or without platinum 5FU | - | - | - |
1st line advanced or metastatic HNSCC – with or without platinum 5FU
PD-L1 testing: companion - CPS ≥ 1
PD-L1 22C3 pharmDx
- EnVision FLEX visualization system on Autostainer Link 48
- HNSCC interpretation guide